Differential reinforcing effects of cocaine and GBR-12909: Biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system

Journal of Neuroscience

Volumn 16, Issue 23, 1996, Pages 7416-7427

  Tella, Srihari R ^a,b   Ladenheim, Bruce ^b   Andrews, Anne M ^c   Goldberg, Steven R ^a,b   Cadet, Jean Lud ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

cocaine; dopamine; dopamine receptors; dopamine transporters; drug addiction; drug withdrawal; GBR 12909; neuroadaptation; reinforcing effects; self administration

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOMPERIDONE; DOPAMINE; DOPAMINE 1 RECEPTOR; MIANSERIN; VANOXERINE; WATER;

ADAPTATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

EID: 0029909269     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-23-07416.1996     Document Type: Article

References (68)

1. Alburges ME, Crouch DJ, Andrenyak DM, Wamsley JK (1996) Lack of long-term changes in cocaine and monoamine concentrations in rat CNS following chronic administration of cocaine. Neurochem Int 28:51-57.
2. 3-MPTP and MPTP. J Neurochem 60:1167-1170.
3. Ator NA, Griffiths RR (1992) Differential sensitivity to madozlam discriminative stimulus effects following self-administered versus response-independent midazolam. Psychopharmacology 110:1-4.
4. Baumann MH, Raley TJ, Partilla JS, Rothman RB (1993) Biosynthesis of dopamine and serotonin in the rat brain after repeated cocaine injections: a microdissection mapping study. Synapse 14:40-50.
5. Baumann MH, Char GU, de Costa BR, Rice KC, Rothman RB (1994) GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. J Pharmacol Exp Ther 271:1216-1222.
6. Bergman J, Madras BK, Johnson SE, Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155.
7. 125I]iodophenyl)tropane-2β-carboxylic acid isopropyl ester. Mol Pharmacol 47:779-786.
8. Claye LH, Akunne HC, Davis MD, DeMattos S, Soliman KFA (1995) Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration. Mol Neurobiol 11:55-66.
9. DeMattos SB, Pugsley TA, Shih YS, Whetzel LM, Georgic DH, Van Leeuwen RG, Mackenzie SJ, Smith SA (1993) Identification and characterization of a dopamine D3 selective compound, PD 128907. Soc Neurosci Abstr 19:77.
10. Deneau G, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey: a measure of psychological dependence. Psychopharmacologia 16:30-48.
11. 3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domains. Neurochem Res 19:201-208.
12. Dworkin SI, Mirkis S, Smith JE (1995) Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug. Psychopharmacology 117:262-266.
13. Elmer GI, Brockington A, Gorelick DA, Carroll FI, Rice KC, Matecka D, Goldberg SR, Rothman RB (1996) Cocaine cross-sensitization to dopamine uptake inhibitors: unique effects of GBR 12909. Pharmacol Biochem Behav 53:911-918.
14. Ettenberg A, Geist TD (1991) Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology 103:455-461.
15. Farfel GM, Kleven MS, Woolverton WL, Seiden LS, Perry BD (1992) Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkeys. Brain Res 578:235-243.
16. Giros B, Wang YM, Suter S, McLeskey SB, Pifl C, Caron MG (1994) Delineation of discrete domains for substrate, cocaine and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 269:15985-15988.
17. Glowa JR, Wojnicki FHE, Matecka D, Rice KC, Rothman RB (1995) Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding. II. Comparisons with other drugs and repeated administrations. Exp Clin Psychopharmacol 3:232-239.
18. Goldberg SR, Spealman RD (1982) Maintenance and suppression of behavior by intravenous nicotine injections in squirrel monkeys. Fed Proc 1:216-220.
19. Griffiths RR, Bigelow GE, Henningfield JE (1980) Similarities in animal and human drug taking behavior. In: Advances in substance abuse: behavioral and biological research (Mello NK, ed) pp 1-90. Greenwich, CT: JAI.
20. Grilli M, Sanna E, Hanbauer I (1988) Role of corticostriatal nerve projections in the regulation of binding sites for dopamine uptake blockers. Soc Neurosci Abstr 14:929.
21. Henry DJ, White FJ (1991) Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther 258:882-890.
22. Henry DJ, White FJ (1995) The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J Neurosci 15:6287-6299.
23. Howell LL, Byrd LD (1991) Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J Pharmacol Exp Ther 258:178-185.
24. Hurd YL, Weiss F, Koob GF, And N-E, Ungerstedt U (1990) Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study. Brain Res 498:199-203.
25. 3H]dopamine uptake in vitro in rat nucleus accumbens but not in striatum. Brain Res 531:338-341.
26. Johanson CE, Balster RL (1978) A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys. Bull Narc 30:43-54.
27. Johanson CE, Fischman MW (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41:3-52.
28. 3H]mazindol binding sites from alkylation by N-ethylmaleimide. Eur J Pharmacol 227:411-415.
29. Kalivas PW, Stewart J (1991) Dopamine transmission in drug- and stress-induced behavioral sensitization. Brain Res Rev 16:223-244.
30. Katz JL, Griffiths JW, Sharpe LG, De Souza EB, Witkin JM (1993) Cocaine tolerance and cross-tolerance. J Pharmacol Exp Ther 264:183-192.
31. King GR, Ellinwood Jr EH, Silvia C, Joyner CM, Xue Z, Caron MG, Lee TH (1994) Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function. J Pharmacol Exp Ther 269:743-749.
32. Kitayama S, Shimada S, Xu H, Markham L, Donovan DM, Uhl GR (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci USA 89:7782-7785.
33. Kleven MS, Woolverton WL, Seiden LS (1988) Lack of long-term monoamine depletions following repeated or continuous exposure to cocaine. Brain Res Bull 21:233-237.
34. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
35. Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
37. Meil WM, Roll JM, Grimm JW, Lynch AM, See RE (1995) Tolerance-like attenuation to contingent and noncontingent cocaine-induced elevation of extracellular dopamine in the ventral striatum following 7 days of withdrawal from chronic treatment. Psychopharmacology 118:338-346.
38. Melia KF, Spealman RD (1991) Pharmacological characterization of the discriminative stimulus effects of GBR12909. J Pharmacol Exp Ther 258:626-632.
39. Nestler EJ (1994) Molecular neurobiology of drug addiction. Neuropsychopharmacology 11:77-87.
40. Nissbrandt H, Engberg G, Pileblad E (1991) The effects of GBR 12909, a dopatnine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra. Naunyn Schmiedebergs Arch Pharmacol 344:16-28.
41. Parsons LH, Smith AD, Justice JB Jr (1991) Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse 9:60-65.
42. Peris J, Boyson SJ, Cass WA, Curella P, Dwoskin LP, Larson G, Lin L-H, Yasuda RP, Zahniser NR (1990) Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J Pharmacol Exp Ther 253:38-44.
43. Pettit HO, Justice JB (1989) Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 34:899-904.
44. Pilotte NS, Sharpe LG, Kuhar MJ (1994) Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J Pharmacol Exp Ther 269:963-969.
45. 3H]cocaine binding sites. Naunyn Schmiedbergs Arch Pharmacol 351:136-145.
46. Reith MEA, de Costa BR, Rice KC, Jacobson AE (1992) Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935, and dopamine to the dopamine transporter. Eur J Pharmacol 227:417-425.
47. Roberts DCS (1993) Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats. Psychopharmacology 111:202-206.
48. Robertson MW, Leslie CA, Bennett Jr JP (1991) Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Res 538:337-339.
49. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157-198.
50. Rothman RB, Glowa JR (1995) A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development: focus on GBR 12909. Mol Neurobiol 11:1-19.
51. Rothman RB, Mele A, Reid AA, Akunne HC, Greig N, Thurkauf A, de Costa BR, Rice KC, Pert A (1991) GBR 12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol Biochem Behav 40:387-397.
52. Rothman RB, Greig N, Kim A, de Costa BR, Rice KC, Carroll FI, Pert A (1992) Cocaine and GBR 12909 produce equivalent motoric responses at different occupancy of the dopamine transporter. Pharmacol Biochem Behav 43:1135-1142.
53. 125I]RTI-55. J Pharmacol Exp Ther 270:296-309.
54. 2-like dopamine receptor agonists. Science 271:1586-1589.
55. 3H]mazindol-labelling of dopamine transporter in nucleus accumbens. Eur J Pharmacol 203:141-144.
56. Siegel S (1988) Drug anticipation and drug tolerance. In: The psychopharmacology of addiction (Lader M, ed), pp 73-96. New York: Oxford UP.
57. Spyraki C, Sealfon SC (1993) Regulation of dopamine D2 receptor mRNA expression in the olfactory tubercle by cocaine. Mol Brain Res 19:313-317.
58. Tella SR (1995) Effects of monoamine reuptake inhibitors on cocaine self-administration in rats. Pharmacol Biochem Behav 51:687-692.
59. Tella SR (1996) Possible novel pharmacodynamic action of cocaine: cardiovascular and behavioral evidence. Pharmacol Biochem Behav 54:343-354.
60. Unterwald EM, Ho A, Rubenfeld M, Kreek MJ (1994) Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration. J Pharmacol Exp Ther 270:1387-1397.
61. Wamsley JR, Alburges ME (1993) Cocaine causes a time dependent and dose dependent increase in D1 receptors and dopamine transporters. Proc West Pharmacol Soc 36:277-282.
62. Weiss F, Hurd YL, Ungerstedt U, Markou A, Plotsky PM, Koob GF (1992) Neurochemical correlates of cocaine and ethanol self-administration. Ann NY Acad Sci 654:220-241.
63. 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci 14:2966-2979.
64. Wise RA, Murray A, Bozarth MA (1990) Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology 100:355-360.
65. Wise RA, Newton P, Leeb K, Burnette B, Pocock D, Justice Jr JB (1995) Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology 120:10-20.
66. Witkin JM, Nicholos DE, Terry P, Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257:706-713.
67. Yeh SY, DeSouza EB (1991) Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on monoamine neurons. Drug Alcohol Depend 27:51-61.
68. 3H]dopamine. Neuropharmacology 29:475-486.